Tseng Po-Yuan, Rele Shyam S, Sun Xue-Long, Chaikof Elliot L
School of Chemical Engineering, Georgia Institute of Technology, Atlanta, 30320, USA.
Biomaterials. 2006 Apr;27(12):2637-50. doi: 10.1016/j.biomaterials.2005.10.025. Epub 2006 Jan 10.
Membrane-mimetic thin films containing thrombomodulin (TM) and/or heparin were produced and their capacity to inhibit thrombin generation evaluated in a continuous flow system. Tissue factor (TF) along with TM and heparin were immobilized in spatially restricted zones as components of a membrane-mimetic film. Specifically, TF was positioned as an upstream trigger for thrombin generation and TM and/or heparin positioned over the remaining downstream portion of test films. Peak and steady-state levels of thrombin were decreased by antithrombin III (ATIII), as well as by surface bound heparin and TM. Although physiologic concentrations of ATIII have the capacity to significantly inhibit thrombin activity, surface bound TM and heparin nearly abolished steady-state thrombin responses. In particular, surface bound TM appears to be superior to heparin in reducing local thrombin concentrations. These studies are the first to demonstrate the additive effect of surface bound heparin and TM as a combined interactive strategy to limit TF-induced thrombin formation.
制备了含有血栓调节蛋白(TM)和/或肝素的膜模拟薄膜,并在连续流动系统中评估了它们抑制凝血酶生成的能力。组织因子(TF)与TM和肝素一起作为膜模拟薄膜的成分固定在空间受限区域。具体而言,TF被定位为凝血酶生成的上游触发因素,而TM和/或肝素则定位在测试薄膜剩余的下游部分。抗凝血酶III(ATIII)以及表面结合的肝素和TM可降低凝血酶的峰值和稳态水平。尽管生理浓度的ATIII有能力显著抑制凝血酶活性,但表面结合的TM和肝素几乎消除了稳态凝血酶反应。特别是,表面结合的TM在降低局部凝血酶浓度方面似乎优于肝素。这些研究首次证明了表面结合的肝素和TM作为一种联合交互策略来限制TF诱导的凝血酶形成的相加作用。